Dublin-based healthcare giant Cardinal Health on Friday agreed to pay $44 million to settle multiple lawsuits regarding the distribution of various controlled substances.

Cardinal Health admitted that it failed to report large orders for powerful painkillers like oxycodone in 2011 and 2012. The company hit the $44 million settlement with the U.S. Department of Justice (DoJ).

Kinray LLC., a New York-based subsidiary of Cardinal Health, also agreed to pay $10 million as part of the settlement.

Craig Morford, the company’s chief legal & compliance officer, claimed that the company remained committed to working with public as well as private partners to do their part and find solutions.

Confirming the settlement, Morford said, “These agreements allow us to move forward and continue to focus on working with all participants in addressing the epidemic of prescription drug abuse. Cardinal Health is committed to working with both public and private partners to do our part and find solutions.”

Amid ruthlessly growing opioid epidemic, battling over-prescription of painkillers like oxycodone has become a priority for the U.S. law enforcement. Painkillers like oxycodone contain chemicals found in drugs like opium and heroin. Deaths from opioid abuse have skyrocketed across the nation in recent years.

– Caroline Robinson
NorCal.news

Follow Prescription Advisory

When a clinician is prescribing a controlled substance, readily available information about the drugs that a patient is receiving from other providers can be a critically important component of the decision-making process…Increasingly, these [PDMP] programs have evolved into a useful tool for the clinician who must incorporate careful risk management into the prescribing of opioid analgesics or any other controlled substance.

Increasingly, these programs have evolved into a useful tool for the clinician who must incorporate careful risk management into the prescribing of opioid analgesics or any other controlled substance Prescription Drug Monitoring Programs Serve a Vital Clinical Need.

Editorial  Pain Medicine, The American Academy of Pain Medicine; 2011;12:845

The CDC advises providers to use PDMPs… States should consider ways to increase their use … available real-time, and alerts to prescribers.

Center for Disease Control and Prevention
Rick Bunker

Rick Bunker

Rick Bunker is a co-founder, and the CEO of Prescription Advisory Systems and Technology (P.A.S.T.). In this role, he is responsible for capital formation and corporate development.
Rick Bunker
Prescription Advisory Systems & Technology

Request a PastRx Demo

We will contact you to arrange a demo at your convenience.

You have Successfully Subscribed!

Prescription Advisory Systems & Technology

Contact PastRx

A representive will be in touch to answer any questions or concerns you might have.

Thank you! A Prescription Advisory representative will contact you shortly.

Share This